GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) has submitted an application to the American Food and Drug Administration (FDA) regarding market approval of STEEN Solution™, a product used for cleansing and evaluation of lungs outside the body (ex vivo) before transplantation.
